The over-expression of MDM2 due to a single nucleotide polymorphism of thymine to guanine (T to G) at position 309 of the MDM2 gene (mdm2 SNP309) is associated with increased cancer incidence and aggressiveness [20–23]. The gene discussed is MDM2; the disease is cancer.